v3.25.3

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2025	Dec. 31, 2024
Current Assets:
Cash and cash equivalents	$ 590,075	$ 574,485
Short-term investments	3,762,602	2,905,438
Accounts receivable (includes related party of $0 and $3,007, respectively)	7,925	13,043
Inventory	160,225	174,578
Prepaid expenses and other current assets	296,551	293,597
Total Current Assets	4,817,378	3,961,141
Intangible assets, net	308,562	260,727
Other assets	(0)	864
Total Assets	5,125,940	4,222,732
Current Liabilities:
Accounts payable (Includes related party of $2,911 and $0, respectively)	67,493	155,949
Accrued expenses (Includes related party of $206,000 and $240,000, respectively)	290,031	390,745
Total Current Liabilities	357,524	546,694
Total Liabilities	357,524	546,694
Stockholders’ Equity:
Common stock, $0.001 par value; 100,000,000 shares authorized; 18,189,606 and 13,303,523 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively	18,190	13,304
Accumulated other comprehensive loss	(631)	(513)
Additional paid in capital	95,241,723	88,308,478
Accumulated deficit	(90,490,866)	(84,645,231)
Total Stockholders’ Equity	4,768,416	3,676,038
Total Liabilities and Stockholders’ Equity	$ 5,125,940	$ 4,222,732

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Nexalin Technology, Inc. 10-Q